TooBrief TooBrief

Home / Headlines

Dr Reddy’s Mexico API facility gets two observations from USFDA

Business News Today: Latest Business News, Finance News · DistrictNews · 2026-09-12

Dr Reddy’s Mexico API facility gets two observations from USFDA

Dr Reddy’s Mexico API facility gets two observations from USFDA. Pharmaceutical major Dr Reddy's Laboratories says US health regulator conducted a records assessment of its active pharmaceutical ingredient (API) manufacturing facility in Mexico. The assessment at the facility -- Industrias Químicas Falcon de México, SA de CV -- has been completed by the United States Food and Drug Administration (USFDA.

Why it matters. Why it matters: Dr Reddy’s Mexico API facility gets two observations from USFDA.

Read original on Business News Today: Latest Business News, Finance News Get the app

Licensed summary · LicensedSummary

Related briefs